Immuno-oncology β current activities and future opportunities
- π€ Speaker: Robert Wilkinson, Edd Poon and Simon Barry π Website
- π Date & Time: Monday 16 November 2015, 16:30 - 18:00
- π Venue: Building 310 on the Cambridge Science Park
Abstract
As part of our Science@Darwin seminars we are hosting a session on immuno-oncology with a focus on some of our current activities as well as what we see as future opportunities.
Come along and hear from some of our leading scientist about: β’ Immuno-oncology Background Science and Durvalumab (MEDI4736), an antiβPD-L1 antibody by Robert Wilkinson β’ Targeted therapies: preclinical assessment of immunobiology and combination potential with checkpoint inhibitors by Edd Poon β’ Small molecule opportunities to enhance anti-tumour immunity and the tumour microenvironment by Simon Barry
We will open the doors from 4.00pm, talks 4.30pm-6pm followed by general networking and refreshments. Please register at https://www.eventbrite.co.uk/event/19226769786
Series This talk is part of the Science@Darwin series.
Included in Lists
Note: Ex-directory lists are not shown.
![[Talks.cam]](/static/images/talkslogosmall.gif)



Monday 16 November 2015, 16:30-18:00